13G Filing: Ardsley Partners and Bioscrip Inc. (BIOS)

Page 13 of 13

Page 13 of 13 – SEC Filing

 

CUSIP No. 09069N108

13G/A Page
13 of 13 Pages
     
  January 26, 2018  
  Date  
     
  ARDSLEY PARTNERS FUND II, L.P.  
  By: Ardsley Partners I, General Partner  
     
  /s/
Steve Napoli
 
  Signature  
 
  Steve Napoli/General
Partner
 
     
  January 26, 2018  
  Date  
     
  ARDSLEY PARTNERS ADVANCED HEALTHCARE FUND,
L.P.
 
 

By: Ardsley Partners I, General Partner

 
     
  /s/ Steve
Napoli
 
  Signature  
     
  Steve Napoli/General
Partner
 
     
  January 26, 2018  
  Date  
     
  ARDSLEY DUCKDIVE FUND, L.P.  
 

By: Ardsley Partners I, General Partner

 
     
  /s/ Steve
Napoli
 
  Signature  
     
  Steve Napoli/General
Partner
 
     
  January 26, 2018  
  Date  
     
  ARDSLEY HEALTHCARE FUND, L.P.  
 

By: Philip Hempleman, General Partner

 
     
 

Steve Napoli/Attorney-in Fact for Philip J. Hempleman

 
 

Name/Title

 
     
 

Steve Napoli/General Partner

 

 

*
Executed by Steve Napoli as Attorney-in-Fact for Philip J. Hempleman. The Power of Attorney for Mr. Hempleman is attached as Exhibit
2 to the Statement on Schedule 13G/A with respect to the Common Stock of Vaxgen, Inc., filed on February 15, 2006, and is incorporated
herein by reference.

 

The original
statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement
is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing
person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided,
however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

 

NOTE:
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See
§240.13d-7 for other parties for whom copies are to be sent.

 

Attention: Intentional misstatements
or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)

Follow Option Care Health Inc. (NASDAQ:OPCH)

Page 13 of 13